8-K: Integer Holdings Announces Conversion Period for 2.125% Convertible Senior Notes Due 2028

Integer Holdings Corporation has announced the start of the conversion period for its 2.125% Convertible Senior Notes due 2028, allowing holders to convert their notes into cash and/or company stock.

Summary

• Integer Holdings Corporation announced that holders of its 2.125% Convertible Senior Notes due 2028 can convert their notes between April 1, 2025, and June 30, 2025.
• The notes are convertible into cash up to the principal amount, and the remainder, if any, can be settled in cash, shares of the company's common stock, or a combination thereof, at Integer's election.
• The notes became convertible because the stock price exceeded 130% of the conversion price for at least 20 trading days during a 30-day period ending March 31, 2025.
• The conversion rate is 11.4681 shares per $1,000 principal amount of notes, equivalent to a conversion price of approximately $87.20 per share.
• Holders can obtain the notice with terms, conditions, and procedures from The Depository Trust Company or Wilmington Trust, National Association, the conversion agent.

Sentiment

Score: 6

Explanation: The announcement is neutral, simply informing noteholders of their conversion options. It doesn't indicate positive or negative performance, but rather a procedural step.

Positives

• The conversion option provides flexibility to noteholders, allowing them to potentially benefit from the company's stock performance.
• Integer has the option to manage its cash and equity by choosing the settlement method for the conversion.

Risks

• The company's stock price could decline, making the conversion less attractive for noteholders.
• Integer may need to use cash to settle the conversion, which could impact its cash flow.

Future Outlook

Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.

Management Comments

• None of the Company, its Board of Directors or its employees has made or is making any representation or recommendation to any holder as to whether to exercise or refrain from exercising the Conversion Option.

Industry Context

Integer Holdings is a leading medical device contract development and manufacturing organization (CDMO). The announcement is a routine part of managing their capital structure and providing options to debt holders.

Comparison to Industry Standards

• Convertible notes are a common financing tool in the medical device industry, often used by companies like Integer to raise capital while offering investors potential upside from stock appreciation.
• The conversion price of $87.20 per share will be compared to the current trading price of ITGR to determine the attractiveness of conversion for noteholders.
• Similar companies like Medtronic or Boston Scientific also manage their debt through various instruments, including convertible notes, to optimize their capital structure.

Stakeholder Impact

• Noteholders have the option to convert their notes, potentially impacting their investment returns.
• Shareholders may see dilution if Integer chooses to settle the conversion with shares.
• The company's cash flow could be affected depending on the settlement method chosen.

Next Steps

• Noteholders will decide whether to convert their notes during the conversion period.
• Integer will monitor the conversion activity and determine the settlement method (cash, shares, or a combination) based on the indenture agreement.

Key Dates

Keywords

Convertible Notes, Integer Holdings, Conversion Period, Senior Notes, ITGR, Medical Device